Viewing nowCombinationRivaroxaban High Tablet 4/80/5 mg (Pitavastatin Calcium Hydrate, Valsartan, Amlodipine Besylate)
Valsartan 80mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.

MFDS item code 202502535 · Approved 2025.09.24 · Insurance code 644915450
Treatment of primary hypercholesterolemia, mixed dyslipidemia, and essential hypertension
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled by taking amlodipine and valsartan together, and who also need to take pitavastatin. Amlodipine and valsartan help lower blood pressure, while pitavastatin is effective in controlling cholesterol levels by improving hypercholesterolemia and dyslipidemia. This medication is used to improve cardiovascular health by managing blood pressure and blood lipids simultaneously.
Take 1 tablet once daily with water. It is recommended that the medicine be taken at the same time each day, if possible (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and pitavastatin. Patients taking the amlodipine/valsartan combination and pitavastatin as separate medicines may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination It is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted before administering the amlodipine/valsartan combination. However, a direct switch to the amlodipine/valsartan combination may be considered if blood pressure is not controlled with monotherapy using either component, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients with renal impairment: No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater). Do not administer the amlodipine/valsartan combination to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan must not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years and older: Use caution when increasing the dose. ▷ Pitavastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient's response. The therapeutic effect of this medicine is maintained with continued administration.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so women who are pregnant or may become pregnant should not use this medication. Additionally, individuals who are allergic to any of the components or similar medications, those with severe liver impairment, severe kidney impairment, or active liver disease should avoid taking this medication. Patients with sodium or fluid deficiency should stabilize their condition before starting this medication and monitor blood pressure and symptoms closely during treatment. If there is hyperkalemia or if other medications that can elevate potassium levels are being taken, potassium levels should be checked frequently. Patients with compromised kidney function or renal artery stenosis require careful monitoring due to the risk of worsening kidney function. Patients with heart failure or after a myocardial infarction should closely monitor changes in kidney function and blood pressure when taking this medication, especially if heart failure is severe. This medication can lower blood pressure, so caution is needed in patients with hypotension or severe aortic stenosis. Some components of this medication are metabolized in the liver, so patients with reduced liver function may require dose adjustments and should undergo regular liver function tests. Muscle pain, weakness, or in severe cases muscle damage known as rhabdomyolysis may occur, so if these symptoms appear, patients should consult with a doctor immediately. During the use of this medication, side effects such as headache, dizziness, edema, and dyspepsia may occur, so if symptoms are severe or persistent, patients should inform healthcare providers. Caution is necessary when driving or operating machinery as dizziness or fatigue may occur. This medication may interact with other drugs, so it is important to inform healthcare providers about any other medications being taken. Women who are pregnant or breastfeeding should not take this medication, and if pregnancy is confirmed while taking it, treatment should be stopped immediately. Elderly patients may be more sensitive to this medication, so starting with a lower dose and careful monitoring of their condition is advised. In case of an overdose, severe blood pressure drop or shock may occur, so adherence to the prescribed dosage is crucial, and immediate emergency treatment is needed if unusual symptoms arise. This medication should be kept out of the reach of children and stored in its original container to prevent misuse or deterioration in quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored at room temperature between 1 and 30 degrees Celsius, and it is important to keep it in a well-closed container to prevent air exposure. This helps to maintain the effectiveness of the medication and prevent degradation.
Dark pink round film-coated tablets
30 tablets/PVC [6 tablets/PVC x 5]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 80mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.